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Abstract Meprins are astacin-like metalloproteases of renal
and intestinal epithelia and embryonic neuroepithelial cells. The
full length cDNA of the human meprin K subunit has been
overexpressed in baculovirus-infected insect cells yielding the
tetrameric proprotein which could be proteolytically activated
and affinity-purified to homogeneity. Recombinant meprin K
hydrolyzes the synthetic substrate N-benzoyl-tyrosyl-p-amino-
benzoic acid (PABA-peptide) and cleaves by limited proteolysis
the basement membrane constituents laminin 1 and laminin 5.
This supports a concept that meprin K, when basolaterally
secreted by human colon carcinoma epithelial cells, increases the
proteolytic capacity for tumor progression in the stroma.
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1. Introduction
Meprins (EC. 3.4.24.18) are zinc-metalloproteases of the
astacin family and of the metzincin superfamily [1^3]. Astacin
family members such as tolloid from Drosophila [4], Xenopus
[5] and zebra ¢sh [6] are involved in embryonic pattern for-
mation or play an important role in tissue remodeling as in
the case of the human bone morphogenetic protein 1. The
latter is identical to the procollagen C-proteinase, a key player
in the biosynthesis of collagen [7^9].
Meprins are mainly expressed both as membrane bound or
secreted forms in intestinal and kidney brush border epithelial
cells [10,11]; minor expression has been reported in embryonic
neuroepithelial cells and leukocytes of the lamina propria
[12,13]. They exist as two homologous multidomain subunits,
K and L, each comprising an N-terminal propeptide followed
by the catalytically active protease domain, the meprin, A5
protein, receptor protein-tyrosine phosphatase W (MAM)-do-
main, the meprin and TRAF homology (MATH) and after-
MATH domains, an epidermal-growth-factor-like domain
(EGF), a transmembrane region and a short cytoplasmic tail
[14,15]. Apart from the protease domain the function of the
other domains are not yet understood in detail, but they most
likely mediate protein-protein interactions [16]. In addition,
the K subunit alone possesses an inserted domain (I-domain)
which is responsible for di¡erent processing of the subunits
along the secretory pathway; physiological cleavage of the K
subunit within the I-domain results in loss of the membrane
anchor and subsequent secretion [17,18]. The L subunit of
human meprin on the other hand is cleaved only to a minor
degree at a di¡erent site [19] and predominantly remains
membrane bound. Therefore, membrane localization of the
K subunit is solely due to an association with L by intermo-
lecular disul¢de bonding between the MAM domains [18,20].
Two dimers are clustered together by non-covalent interac-
tions to form tetrameric complexes [21].
Meprins cleave a wide range of biologically active peptides
such as bradykinin, substance P, neurotensin, parathyroid
hormone or gastrin in vitro [10,22^24]. Furthermore, they
are capable of degrading extracellular matrix components
and were identi¢ed as the main matrix degrading activity in
mouse kidney [25]. Despite this rather broad range of poten-
tial substrates the basic physiological function remains spec-
ulative. Generally, meprins are sorted to the apical plasma
membrane [18]. However, under certain pathological condi-
tions they also appear basolaterally. This was shown for me-
prin K in mouse kidney after reperfusion of the tissue follow-
ing epithelial cell injury [26] and for meprin K in the human
colon carcinoma cell line Caco-2 [27]. Furthermore, in isolated
human colon carcinoma tissue, meprin K activity was shown
to be increased. Hence, missorting and subsequent stromal
localization of meprin could increase the proteolytic capacity
in the stroma and thereby contribute to the migration and
invasion of tumor cells [27].
To further characterize the protein-protein interaction of
meprin with other proteins and possible substrates and for
structural analysis, a substantial amount of the enzyme is
required. So far, no heterologous expression has yielded su⁄-
cient amounts of active protein for such investigations. Here
we report on an expression system for the production of hu-
man promeprin K in baculovirus transfected insect cells and
its subsequent puri¢cation by an inhibitor based, active site
directed a⁄nity chromatography. This puri¢cation has al-
lowed us to characterize the cleavage speci¢city towards iso-
lated compounds of the basement membrane.
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2. Materials and methods
Cloning was performed following standard procedures [28]. Full
length human meprin K cDNA was excised from pSG5 (Stratagene,
La Jolla, CA, USA) using BamHI and SpeI restriction sites and li-
gated into pFastBac (Gibco Life Technologies, Paisley, UK), resulting
in pFastBac/humepK. A truncated version of human meprin K con-
taining only the catalytic domain (corresponding to amino acids 1^
263 of human meprin K) was produced by polymerase chain reaction
using the primers:
mep-sense 5P CTCGGATCCAGCAATGCTTGGATTAGA
mep-antisense 5P CTCGAATTCCTAAGTGTGAGTTGTGGTG-
CAATT
thereby introducing a stop codon at the end of the catalytic domain
and BamHI/EcoRI restriction sites. This fragment was ligated into
pFastBac resulting in pFastBac/protease. The integrity of the insert
was veri¢ed by DNA sequencing. Creation of recombinant viral DNA
was performed using the Bac-to-Bac expression system (Gibco Life
Technologies, Paisley, UK). Shortly, the foreign cDNA is ligated into
the cloning plasmid pFastBac that contains an expression cassette
including the strong viral polyhedrin promoter from Autographa cali-
fornica nuclear polyhedrosis virus. The complete expression cassette is
transposed into the viral genome that is localized on a F-plasmid
(bacmid) which can be propagated in and isolated from Escherichia
coli cells. By this procedure, three di¡erent types of recombinant viral
DNA termed bac/humepK, bac/protease and bac/mock were created
and used to transfect insect cells.
2.1. Cell culture and transfection of insect cells
Spodoptera frugiperda (SF)21 and SF9 insect cells were cultured
adherently growing at 27‡C in Grace’s insect media supplemented
with 10% fetal bovine serum, 4 mM glutamine, 50 units/ml penicillin
and 50 Wg/ml streptomycin. Cells were split 1:20 every ¢ve days and
media was changed every second day. SF21 insect cells in suspension
were cultured at 27‡C in Grace’s insect media supplemented with 5%
fetal bovine serum, 4 mM glutamine, 50 units/ml penicillin, 50 Wg/ml
streptomycin and 1% (v/v) pluronic lipid additive. Cells were kept in
glass spinner £asks at a constant stirring speed of 80 rpm. They were
seeded at a density of 2U104 cells/ml and cell growth was monitored
regularly (all media were purchased from Gibco Life Technologies,
Paisley, UK).
For transfection with recombinant viral DNA, SF21 insect cells
were seeded at a density of 2U105 cells/ml in 75 cm2 £asks. At 80%
con£uency cells were transfected in media omitting any supplements
by using the Lipofectin transfection reagent (Gibco Life Technologies,
Paisley, UK) according to manufacturer’s manual. Protein expression
was analyzed after 72 h.
Transfected cells secreting recombinant baculoviruses were used to
infect fresh insect cells. To obtain a high virus titer, harvested bacu-
loviruses after transfection were ampli¢ed twice in adhesion cultures
of SF9 at 80% con£uency. For large scale expression of meprin con-
structs, 500 ml suspension cultures of SF21 insect cells were infected
at a density of 5U105 cells/ml with a twice ampli¢ed virus stock.
Expression was stopped after 90 h and media were stored at 320‡C
until further use.
2.2. Analysis of protein expression
Heterologously expressed promeprin K was activated by limited
proteolysis with bovine trypsin (20 Wg/ml, 10 min at 37‡C). Meprin
K activity was detected using N-benzoyl-L-tyrosyl-p-aminobenzoic acid
(PABA-peptide) as a substrate [29] and analyzed as described previ-
ously [10]. To check recombinant protein expression, media contain-
ing secreted proteins and cell lysates were analyzed by immunoblot-
ting or PABA-peptide hydrolase activity. Media were used without
further puri¢cation. Cell lysates were prepared from 1 ml aliquots of
cell culture by centrifugation for 10 min at 500Ug. The cell pellet was
washed twice with 0.02 M phosphate-bu¡ered saline (PBS) pH 7.4
and ¢nally resuspended in 300 Wl of the same bu¡er containing 1%
Triton X-100, 10 mM pefabloc, 50 WM leupeptin, 10 WM pepstatin,
10 WM aprotinin and 17.4 WM benzamidine. The solution was incu-
bated on ice for 30 min and then centrifuged for 10 min at 12 000 rpm.
The protein concentration of the supernatant (cell lysate) was deter-
mined according to Bradford [30] using the Bio-Rad protein assay kit
(Bio-Rad, Hercules, USA) and all samples were diluted to the same
protein concentration.
SDS-PAGE was performed as described by Laemmli [31]. For im-
munoblot analysis proteins were blotted in a semi-dry blotting appa-
ratus onto PVDF membranes. The membranes were blocked in 5%
low fat milk powder for 2 h at room temperature and incubated with
polyclonal anti meprin rabbit antisera overnight at room temperature.
After removal of the antisera and washing in TBS, the membrane was
incubated with horseradish peroxidase linked goat anti rabbit sec-
ondary antibody for 1 h. Visualization of the bands was realized using
the ECL western blot detection kit according to manufacturer’s man-
ual (Amersham Life Sciences, Braunschweig, Germany).
2.3. Puri¢cation of meprin
To the media containing secreted promeprin K-ammoniumsulfate to
60% saturation was added. After a 2 h incubation at 4‡C the precip-
itate containing the enzyme was harvested by centrifugation at
11 000Ug. The pellet was dissolved in 1/20 volume of 0.1 M Tris
pH 8.0 and loaded on a Sephacryl S-300 (Pharmacia Biotech, Uppsa-
la, Sweden) gel ¢ltration column (240 ml). Samples were collected on
a Biologic FPLC System (Bio-Rad, Hercules, USA) in fractions of
8 ml and the speci¢c meprin K activity was measured in each fraction
using the PABA-peptide assay after activation of the proenzyme with
trypsin. Fractions containing the highest meprin activity were pooled
and used for a⁄nity puri¢cation or stored at 320‡C.
The Ki value for meprin inhibition by Pro-Leu-Gly-hydroxamate
[32] was determined by incubating the enzyme with the inhibitor in the
concentration range between 0.1 WM and 10 WM and ¢tting the data
to the equation [33]
vi
v0
 13E0  I0  K i3

E0  I0  K i234UE0UI0
p
2UE0
(v0 = initial rate in the absence of inhibitor; vi = initial rate in the
presence of inhibitor; E0 = enzym concentration; I0 = inhibitor con-
centration). Non-linear regression analysis was achieved using GRA-
FIT (version 4.0, Erithacus Software, UK).
Promeprin K was activated with trypsin, dialyzed against 0.1 M
Tris^HCl, pH 7.5 and further puri¢ed on an a⁄nity column carrying
Pro-Leu-Gly-hydroxamate (480 mg; Bachem, Heidelberg, Germany)
immobilized on 5 g of CH-Sepharose 4B (Pharmacia Biotech, Uppsa-
la, Sweden) according to manufacturer’s instructions. Fractions were
collected in vials pre¢lled with 0.1 M Tris pH 3.5 for immediate
neutralization.
2.4. Laminin cleavage
Laminin 1 isolated from Engelbreth-Holm-Swarm tumor cells was
kindly provided by Dr. Rupert Timpl (Martinsried, Germany). Hu-
man laminin 5 isolated from squamous carcinoma cells was a gift
from Dr. Johannes Eble (Mu«nster, Germany). 11 Wg of laminin
1 and 8 Wg of laminin 5, respectively, were incubated with 0.7 Wg of
a⁄nity-puri¢ed human meprin K for 20 h at 37‡C in 20 mM Tris^
HCl, 15 mM NaCl, 40 mM CaCl2, pH 7.4.
3. Results
3.1. Protein expression
Two meprin K constructs were designed for expression in
baculovirus-infected insect cells. Since SF9- and SF21-cells do
not express endogenous meprin subunits, it was expected that
meprin K be secreted to the media in soluble form (because
the K subunit should be membrane bound only when coex-
pressed with L). Successful transposition of the bac/humepK,
bac/protease and bac/mock constructs into the viral bacmid
was veri¢ed by PCR using a primer pair £anking the inte-
grated cDNA (data not shown).
After transfection of SF21 insect cells with the recombinant
viral DNA, cells were incubated for 72 h at 27‡C. Expression
and secretion of the proteins was veri¢ed by SDS-PAGE and
immunoblot analysis (Fig. 1A). No signals were detected in
wild type cells and cells that were transfected with the con-
struct bac/mock. In contrast, transfection with bac/protease
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resulted in the expression of a protein of 36 kDa in the cell
lysate and a 44 kDa protein in the media. Transfection with
bac/humepK resulted in the expression of protein species with
molecular size of 90 kDa and 105 kDa in the cell lysate and
92 kDa in the media. The e⁄ciency of the expression system
depends on the ability of the transfected insect cells to pro-
duce recombinant baculoviruses that can be used to infect
fresh cells and induce a high level expression of the desired
protein. For this purpose the cell culture media was removed
72 h after transfection and applied to a fresh culture. These
cells again expressed proteins of sizes identical to those in Fig.
1A.
Both the full length meprin K and the protease domain were
expressed as inactive proenzymes containing N-terminal pro-
peptides which need to be removed proteolytically for activa-
tion. Incubation of the expressed proteins with 20 Wg/ml tryp-
sin for 10 min at 37‡C resulted in a shift in molecular size of
the secreted form of full length meprin K from 92 kDa to
85 kDa, which would be expected due to removal of the
propeptide (data not shown). The enzymatic activity of the
Fig. 1. A: Immunodetection of recombinant proteins. Protein expression after transfection of SF21 insect cells with recombinant viral DNA of
the designed constructs bac/humepK (lane 3), bac/protease (lane 2) and bac/mock (lane 1) was analyzed by SDS-PAGE (7.5% PAA) under re-
ducing conditions and subsequent immunoblotting with a meprin speci¢c antibody. Samples of media and cells were taken 72 h after transfec-
tion. Wild type cells (lane 4) were transfected under identical conditions but without DNA. 10 Wg of total protein from cell lysates and 20 Wl
of media were loaded. B: Enzymatic activity of heterologously expressed protein. Samples were taken 72 h after transfection with recombinant
viral DNA bac/protease (prot) and bac/humepK (mep). Wild type cells (wt) were treated identically. 100 Wl of cell culture media and 100 Wl of
cell lysates were incubated with or without 20 Wg/ml trypsin for 10 min at 37‡C before 100 Wl of PABA-peptide was added. After 2 h reactions
were stopped and activities determined.
Fig. 2. A: Elution pro¢le of the a⁄nity chromatography on immobilized PLG-NHOH. Protein concentration and PABA-peptide hydrolyzing
activity are indicated for each fraction. Proteins were loaded on the column in 0.1 M Tris^HCl pH 7.5 and washed with 0.1 M Tris^HCl, pH
7.5/0.5 M NaCl (fractions 1^6). Elution was performed with 0.1 M Tris pH 10.4 (fractions 7^26). B: Characterization of the a⁄nity-puri¢ed
samples. The starting material (5 Wl, lane 1), the non-binding material (10 Wl, lane 2) and fractions 4 (10 Wl, lane 3), 10 (10 Wl, lane 4),
16 (2.5 Wl, lane 5), 18 (10 Wl, lane 6) and 21 (10 Wl, lane 7) from the a⁄nity chromatography column (Fig. 2A) were analyzed by SDS-PAGE
(7.5% PAA) under reducing conditions, blotted and immunodetected using a meprin speci¢c antibody.
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heterologously expressed proteins were determined by using
PABA-peptide. Without trypsin incubation, no activity above
background level could be detected in media or lysates of
transfected cells and wild type cells. PABA-peptide hydrolysis
after incubation with trypsin could only be observed in lysates
and media of cells that were transfected with bac/humepK.
Under these conditions, no activity above background level
was detectable for lysates and media of wild type cells and
bac/protease transfected cells (Fig. 1B)
3.2. Puri¢cation of secreted meprin
For puri¢cation of the expressed protein only secreted full
length meprin was used since this form of the protein under-
went all posttranslational processing steps and was proteolyti-
cally active after trypsin treatment. Meprin accumulation in
the media was monitored regularly and was highest at 90 h
after transfection. No further increase of yield occurred upon
longer incubation (data not shown). Upon Sephacryl S300
gel¢ltration of the precipitated material (50 mg of the total
protein) promeprin K eluted in a high molecular mass fraction
and was separated from the bulk of other proteins corre-
sponding to a molecular mass of V320 kDa (data not
shown). This indicates that meprin is produced by SF21 cells
as an oligomeric complex. An a⁄nity chromatography was
used for further puri¢cation with an immobilized inhibitor
that selectively binds the active form of meprin. Therefore,
meprin containing fractions from gel¢ltration were activated
with trypsin and loaded on a CH-Sepharose a⁄nity column
with immobilized Pro-Leu-Gly-NHOH (Ki = 0.45 WM þ 1 nM
for human meprin K). Meprin activity was completely retained
on the column while the bulk of the protein passed through.
Elution of the bound protein responsible for PABA-peptide
hydrolyzing activity was achieved by elevating the pH above
9.0 (Fig. 2A). The identity of the eluted activity with meprin
was veri¢ed by immunoblotting utilizing a meprin speci¢c
antiserum (Fig. 2B). This puri¢cation procedure is highly e⁄-
cient and yields homogeneous protein after only two column
puri¢cation steps (Fig. 3). The weak bands on the Coomassie
stained gel at lower molecular mass represent C-terminally
truncated forms of meprin after trypsin incubation that are
also recognized by the meprin speci¢c antibody on the immu-
noblot (Fig. 2B). The yield of heterologously expressed me-
prin K is 2.5 mg/l culture media and 750Wg/l after puri¢cation.
The speci¢c activities of the puri¢ed material can be seen in
Table 1.
The puri¢ed and activated recombinant human meprin K
was tested for activity against isolated laminins (Fig. 4). Lam-
inin 1 is cleaved exclusively within the K1 chain resulting in
smaller fragments of 350 and 300 kDa, respectively. Laminin
5 is cleaved within the K3 chain resulting in a fragment of
130 kDa. These fragments point to a high speci¢city of me-
prin towards individual laminin subunits. Control samples of
laminins 1 and 5 incubated in the absence of enzyme under
otherwise identical conditions did not exhibit evidence for
proteolytic degradation.
4. Discussion
A heterologous system for overexpression of promeprin K
was established that allows the subsequent puri¢cation of sig-
ni¢cant amounts of protein for functional and structural stud-
ies. Due to the complex structure of meprins which includes
covalent and non-covalent association of subunits into a tet-
rameric complex [21] and a posttranslational proteolytic cleav-
age that removes the membrane anchor of the K subunit intra-
cellularly [18] many established expression systems turned out
to be unsuitable for larger scale production of meprins. For
example the expression of human meprin K in yeast cells re-
sulted in the synthesis of an inactive protease (own unpub-
lished results).
Both full length human promeprin K and its C-terminally
truncated proprotease domain were expressed in SF21 insect
cells. The full length promeprin K is processed similarly as the
native enzyme [18], losing its membrane anchor during pas-
sage through the secretory pathway and being secreted into
the media as a tetrameric enzyme. Secreted promeprin K can
be activated by limited proteolysis with trypsin, which results
in a protein capable of cleaving the synthetic PABA-peptide
Fig. 3. E⁄ciency of the steps of meprin puri¢cation. Samples from
the cell culture media after meprin expression (2 Wl, lane 1), the me-
prin containing fraction after gel¢ltration (4 Wl, lane 2), the washing
fraction 4 from the a⁄nity chromatography (100 Wl after precipita-
tion with 10% TCA, lane 3) and the meprin containing fraction 16
from the a⁄nity chromatography (40 Wl, lane 4) were analyzed by
SDS-PAGE (7.5% PAA) under reducing conditions and stained
with Coomassie.
Table 1
Puri¢cation of recombinant human meprin K
Puri¢cation step Total protein (mg) Volume (ml) Speci¢c activity (U/mg) Enrichment
Insect cell culture media 9 000 1 000 ^a ^
Precipitation 4 000 50 0.0006 1
S300 gel¢ltration 360 240 0.0055 9.25
A⁄nity chromatography 0.75 14 0.667 120
1 Unit (U) is the enzymatic activity that hydrolyzes 1 Wmol of PABA-peptide/min. Speci¢c activities for human meprin or meprins from other
species against PABA-peptide have not been published so far.
aMeprin activity could not be detected in the crude media, probably due to the presence of an inhibitory activity in the insect cell culture me-
dium containing calf serum proteins.
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and, most speci¢cally, components of the extracellular matrix.
Taken together, these data demonstrate that heterologously
expressed full length meprin resembles the native enzyme in
its typical features.
The shorter version of promeprin K comprising merely the
catalytic domain and the N-terminal propeptide was also se-
creted by the cells, but proved to be inactive. Tsukuba and
Bond [34] observed that truncated forms of mouse meprin K
lacking the MAM domain did not fold properly, turned out to
be inactive and were not secreted by the cells. These di¡er-
ences in intracellular transport could be caused by species
speci¢c properties of the meprins from human and mouse.
So far, there has been no report on a successful expression
of the pure protease domain of meprins in a catalytically
active form.
Full length human promeprin K expressed in SF21 insect
cells can be puri¢ed to homogeneity with only two puri¢ca-
tion steps. By gel ¢ltration, the bulk of low molecular mass
proteins is removed from tetrameric promeprin K for which a
molecular mass of 320 kDa was determined. By applying a
selective a⁄nity chromatography step, meprin K can be ex-
tracted speci¢cally and eluted in pure form. The used inhibitor
PLG-NHOH originally developed for collagenase [32] has al-
ready been adopted successfully to purify recombinant astacin
from E. coli inclusion bodies [35]. The Ki of 0.45 WM for the
inhibition of meprin is lower than the corresponding values
for astacin (16 WM) and collagenase (40 WM). A reason for the
considerably stronger binding of the inhibitor to human me-
prin K could be that the human enzyme has speci¢c features in
its substrate binding cleft which are not seen in rat and mouse
meprin K or meprin L. As shown by X-ray crystal structure
analysis of astacin complexed to PLG-NHOH [36] and by
molecular modelling of various members of the astacin family
and of the metzincin superfamily, the binding site for the Pro-
Leu-Gly-NHOH peptide is considerably conserved [35]. Most
remarkably, the inhibitor’s proline ring is bound into a niche
of the so-called edge L-strand which runs antiparallel to the
inhibitor (or substrate). This conserved niche is shaped by a
triplet of residues, (Trp/His/Tyr)-(Ser/Ala)-(X). In many met-
zincins including mouse and rat meprin K, the X residue is
Tyr. However, in human meprin K X is Glu, whose negatively
charged side chain could interact with the charged imino ni-
trogen of proline and thereby increase the binding a⁄nity of
this inhibitor. Another important feature unravelled by the
described binding of the inhibitor to human meprin K is
that only the trypsin activated enzyme binds to the a⁄nity
column, the proenzyme does not. This provides evidence
that the propeptide which comprises 54 residues might steri-
cally hinder the inhibitor’s access to the active site.
So far, puri¢cation of meprin from various natural tissues
yielded a mixture of K and L subunits. The heterologous ex-
pression of meprin K without contamination by L allows the
assessment of the function of a single subunit. It is known
that both subunits are di¡erentially expressed in a tissue-spe-
ci¢c manner [13], and that not only are their substrate binding
regions di¡erent [3], but also their substrate speci¢cities
strongly deviate [24]. This is the ¢rst proof that puri¢ed hu-
man meprin K cleaves isolated laminin 1 and 5 at distinct sites
within the K1 and K3 chains, respectively, and thus further
evidence that its possible stromal localization in colon cancer
tissue [27] could contribute to the degradation of matrix com-
ponents in vivo. It has been shown that cleavage of laminin 5
by matrix metalloprotease-2 induces the presentation of a
protein domain that acts as an attractant for epithelial cells
in tissues that undergo remodeling [37]. The work presented
here indicates that activated meprin K capable of cleaving
matrix components in a comparable manner as matrix metal-
loprotease-2 [37] may cause an imbalance of proteolytic activ-
ities in stromal areas and thus may contribute to tumor pro-
gression.
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Fig. 4. Proteolytic processing of isolated laminins by a⁄nity-puri¢ed human meprin K. 11 Wg of laminin 1 (A) and 8 Wg of laminin 5 (B) were
incubated with 0.7 Wg of puri¢ed human meprin K for 20 h at 37‡C. Control samples were incubated under identical conditions without me-
prin. After incubation, proteins were precipitated with 20% TCA and 0.15% Triton X-100. For SDS-PAGE under reducing conditions (5^12%
PAA), the samples were resuspended in sample bu¡er. Proteins were detected by Coomassie staining. Subunits of laminins and their physiologi-
cal cleavage products are indicated by Greek letters following current conventions. Asterisks indicate the resulting fragments of laminin incuba-
tion with puri¢ed meprin. Bands at lower molecular masses correspond to antibodies used for laminin puri¢cation.
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